STARS-R Registry: Retrospective Analysis of Poly-4-hydroxybutyrate (P4HB) Scaffold Use
NCT ID: NCT04195854
Last Updated: 2022-02-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1183 participants
OBSERVATIONAL
2019-12-17
2022-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Poly-4-Hydroxybutyrate Scaffold in Rhytidectomy
NCT07132892
Limb Salvage Through Tissue Engineering: A Novel Treatment Modality Using Dehydrated Human Amnion/Chorion Membrane
NCT03521258
Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation
NCT05945329
Dermal and Subcutaneous Augmentation and Skin Assessment After Fat-, Stem Cell and Scaffold Injections
NCT05079243
Tissue-engineered Skin Graft Repair of Autologous Scar Dermal Scaffolds
NCT04389164
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The overall purpose of this study is to gain an understanding of the use and safety of treatments on a historic collection basis. Hypothesis testing is not necessary for the statistical analyses of the generated data. Broad inclusion criteria with few exclusion criteria are utilized so as to avoid censoring historic real-world use of the device.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
P4HB product
Retrospective use of P4HB in various anatomies
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Underwent plastic or reconstructive surgical procedure with P4HB on or after January 1, 2014 until the date of site initiated data collection
* At least 1 visit of documented post-procedure follow-up
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tepha, Inc.
INDUSTRY
C. R. Bard
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
K Doyle
Role: STUDY_DIRECTOR
Tepha, Inc/Galatea Surgical
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aesthetx
Campbell, California, United States
Aesthetic Plastic Surgical Institute
Laguna Beach, California, United States
Revalla Plastic Surgery and Medical Aesthetics
Littleton, Colorado, United States
Sarasota Plastic Surgery
Sarasota, Florida, United States
Politis Plastic Surgery
Tampa, Florida, United States
Southern Plastic Surgery
Duluth, Georgia, United States
Meridian Plastic Surgery
Indianapolis, Indiana, United States
Belcara Health
Baltimore, Maryland, United States
HKB Cosmetic Surgery
Huntersville, North Carolina, United States
Park Cities Surgery
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP-1060
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.